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71. AbstrAct
Background: Otorhinolaryngological (ORL) diseases and hearing loss frequently 
occur among the children of developing countries, but they remain poorly cha-
racterized. A need therefore exists for more comprehensive understanding of the 
background and clinical features of these diseases in resource-poor settings.
Patients and methods: Voluntary paediatric outpatients of various specialties 
were examined at Hospital Pediátrico in Luanda, Angola. Study participants un-
derwent medical history-taking, a thorough physical and ORL examination, hea-
ring screening by brainstem auditory-evoked potentials (BAEP), and, at age 5 or 
older, pure-tone audiometry. Nasopharyngeal smears (NPS) were obtained from 
102 children with respiratory symptoms and screened by polymerase chain reaction 
for human rhino- (HRV) and enterovirus (HEV). We took 18 bacterial culture smears 
from children with chronic suppurative otitis media (CSOM). Clinical data collected 
were compared between 23 children with CSOM vs. 23 age- and gender-matched 
controls, between 61 children with sickle-cell disease (SCD) vs. 61 controls, and 
between 78 human immunodeficiency virus (HIV) –positive children vs. 78 controls. 
Results: In virus screening of 102 NPS specimens, 37 (36%) were positive: 27 (26%) 
for HRV alone, 3 (3%) for HEV alone, and 7 (7%) for HRV+HEV. HRV prevalence 
was highest during the coolest month, July, 47% (26/53), compared to 22% (8/49) 
(p=0.021) in April-to-June. In the CSOM study, HIV positivity occurred in 14/22 
(64%) of the CSOM children vs. none of the controls (p<0.001) and tuberculosis in 
8/22 (36%) vs. none (p=0.002). The most frequent CSOM pathogens were Proteus 
(8/18, 44%) and Pseudomonas species (4/18, 22%). CSOM resulted in hearing 
loss of >25 dB HL in pure-tone averages or BAEP in 17/33 (52%) of the affected 
ears. In the SCD study of 61 SCD children vs. 61 controls, bilateral hearing loss of 
>25 dB HL at any frequency occurred in 9/25 (36%) SCD children vs. 3/28 (11%) 
controls (p=0.047), whereas the prevalence of other ORL findings showed no sig-
nificant difference. Of 78 HIV-positive children vs. 78 controls, ORL pathology was 
present in 72 (92%) HIV-positive vs. 61 (72%) control children (p=0.022). Dental 
caries occurred in 44 (56%) of the HIV-positive children vs. 25 controls (32%) 
(p<0.001), cervical lymphadenopathy >1 cm in 35 (45%) vs. 8 (10%) (p<0.001), 
facial skin lesions in 25 (32%) vs. 4 (5%) (p<0.001), CSOM in 21 (26%) vs. 3 (4%) 
(p<0.001), and bilateral hearing loss of >25 dB HL in PTA or BAEP in 10 (13%) 
vs. one (1%) (p=0.009). 
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Conclusions: In children of tropical Luanda, HRV and HEV emerged during 
respiratory symptoms. CSOM was associated with co-morbidity and hearing loss. 
Hearing loss occurred in SCD. ORL manifestations of HIV infection were common 
and various. In resource-poor settings, ORL and hearing services deserve a higher 
priority.
9Yhteenveto
Taustaa: Korva-, nenä- ja kurkkutaudit (KNK) sekä kuulovauriot ovat kehitysmai-
den lapsilla yleisiä mutta puutteellisesti tutkittuja. Siksi näiden sairauksien tausta 
ja kliininen kuva tarvitsevat tarkempaa määrittelyä.
Potilaat ja menetelmät: Tutkimukseen osallistui vapaaehtoisia eri erikoisalojen 
poliklinikkapotilaita Angolan pääkaupungin Luandan lastensairaalasta (Hospital 
Pediátrico). Osallistujilta kartoitettiin lääketieteelliset taustatiedot, tarkastettiin 
yleis- ja KNK-status sekä tutkittiin kuuloa aivorungon herätevasteiden ja vähin-
tään 5-vuotiailta ilmajohteisen äänesaudiometrian avulla. Sadaltakahdelta hen-
gitystieoireiselta lapselta otettiin nenänielusta tikkunäyte, josta tutkittiin polyme-
raasiketjureaktiolla rino- ja enteroviruksia. Kahdeksaltatoista kroonista märkäistä 
välikorvatulehdusta (chronic suppurative otitis media, CSOM) sairastavalta lapselta 
otettiin bakteeriviljelynäyte. Tutkimustietoa kerättiin ja vertailtiin 23 CSOM:ta sai-
rastavalta lapselta ja 23 ikä- ja sukupuolijakaumaltaan samankaltaiselta verrokilta; 
61 sirppisoluanemiaa sairastavalta ja 61 verrokilta, sekä 78 HIV-infektiota sairas-
tavalta ja 78 verrokilta.
Tulokset: Virusnäytteistä 37/102:ssa (36 %) todettiin virus: 27:ssä (26 %) pelkkä 
rinovirus, kolmessa (3 %) pelkkä enterovirus ja seitsemässä (7 %) molemmat vi-
rukset. Rinoviruksen esiintyvyys oli korkeimmillaan viileän heinäkuun aikana 47 % 
(26/53) ja muina kuukausina (huhti-kesäkuu yhdistettynä) 22 % (8/49) (p=0.021). 
CSOM-tutkimuksessa HIV-infektio todettiin 14/22 (64%) CSOM-potilaalla eikä yh-
delläkään kontrollilapsella (p<0.001), ja tuberkuloosi 8/22:lla (36 %) CSOM-lapsella 
eikä yhdelläkään kontrollilla (p=0.002). CSOM oli tyypillisesti Proteus- (8/18, 44 %) 
tai Pseudomonas -lajien (4/18, 22 %) aiheuttama, ja puhetaajuuksien 0.5-4 kHz 
kuulovaurio (>25 dB HL) ilmeni 52 %:ssa vuotavista korvista. Sirppisoluanemiasta 
kärsivillä lapsilla molemminpuolinen, yleensä lievä kuulovaurio oli 9/25:llä (36 %) ja 
kontrollilapsista 3/28:lla (11 %) (p=0.047); muuten ryhmien välillä ei KNK-löydös-
ten esiintyvyyksissä ollut merkitseviä eroja. Poikkeavia KNK-löydöksiä oli 72/78:lla 
(92 %) HIV-positiivisella vs. 61/78:lla (72 %) kontrollilapsella (p=0.022); kaulan 
alueen imusolmukesuurentumia 35 (45 %) HIV-positiivisella vs. kahdeksalla (10 %) 
kontrollilapsella (p<0.001), iholöydöksiä 25:llä (32 %) vs. neljällä (5 %) (p<0.001), 
CSOM 21:llä (26 %) vs. kolmella (4 %) (p<0.001) ja molemminpuolista kuulonale-
nemaa (>25 dB HL) 10:llä (13 %) vs. yhdellä (1 %) (p=0.009). 
Johtopäätelmät: Trooppisen Luandan lapsilla tavattiin rino- ja enteroviruksia 
hengitystieoireiden yhteydessä. Pitkittynyt märkävuoto välikorvasta liittyi usein 
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yleissairauksiin ja kuulonalenemaan. Sirppisoluanemiaa sairastavilla lapsilla esiintyi 
kuulo-ongelmia. HIV-positiivisista lapsista valtaosalla oli useita KNK-poikkeavuuk-
sia. Kehitysmaiden lasten KNK- ja kuulo-ongelmiin olisi kiinnitettävä enemmän 
huomiota.
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3. abbreviations
AOM Acute otitis media
BAEP Brainstem auditory-evoked potentials
CSOM Chronic suppurative otitis media
HEV Human enterovirus
HIV Human immunodeficiency virus
HRV Human rhinovirus
MEE Middle-ear effusion
NPS Nasopharyngeal smear
ORL Otorhinolaryngological
PTA Pure-tone  average
PCR Polymerase chain reaction
RTI Respiratory tract infection
SCD Sickle-cell disease
TM Tympanic membrane 
WHO World Health Organization
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4. introduction
In developing countries, otorhinolaryngological (ORL) diseases and hearing loss are 
highly common. Despite their frequency, they remain, however, widely neglected. 
Some developing countries have no ORL specialists at all, and even the best ser-
ved areas cannot be compared to the industrialized world. The shortage of ORL 
services includes not only medical specialists, but also the ORL knowledge of local 
general practitioners and nurses, as well as the facilities and technical equipment 
required. The situation is particularly poor in the audiology field. The brain-drain 
phenomenon, challenging the health care of many underserved regions, also extends 
to otolaryngology.1,2
This imbalance sets the young populations of resource-poor countries in an es-
pecially disadvantaged position, as many ORL diseases typically occur in childhood. 
Furthermore, the course of these diseases is often prolonged and complicated in 
children affected by poor hygiene, deficient nutrition, and chronic systemic illnesses. 
In 1996, the World Health Organization (WHO) held an expert meeting to deve-
lop strategies for prevention of deafness due to chronic otitis media in developing 
countries,3 followed by a workshop concerning hearing aids a couple of years later.4 
Unfortunately, the medical and political awareness of the impact of untreated ORL 
diseases on the resource-poor societies has remained low.
Today, medical research concerning developing countries is still largely con-
centrated on life-threatening conditions such as severe infections. Meanwhile, data 
on basic epidemiology and the clinical picture of many common ORL diseases 
are sparse, noncomprehensive, or lacking. However, advances in health care have 
provided a better prognosis for huge numbers of underprivileged children, making 
research and management of their less fulminant diseases even more relevant.    
The present study was launched in Luanda, the capital of Angola, to achieve 
epidemiological and clinical data on childhood ORL diseases, specifically related to 
picornavirus infections, CSOM, sickle-cell disease (SCD), and human immunodefi-
ciency virus (HIV). The republic of Angola is located in southwestern Africa (Figure 
1) and is currently experiencing a reconstruction era after its devastating 27-year 
civil war ending in 2002. Formerly part of the Portuguese Overseas Empire and a 
major sufferer from the Atlantic slave trade, the country became independent in 
1975. Its steady economic growth, mainly fuelled by its rich diamond and petrole-
um resources, has, however, failed to benefit the vast majority of the population, 
such as the millions of inhabitants of the shantytowns of Luanda set up by inland 
escapees from the civil war (Table 1).5
In the present study, it very soon became evident that medical research in resour-
ce-poor settings has as typical challenges how to import the required equipment 
14
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through customs, how to recruit and communicate with people who are commonly 
unfamiliar both with the concept and purpose of research and with basic medical 
knowledge, how to manage problems of electricity supply and electronic devices 
without technical expertise available, and how to make short-term research locally 
useful and ethically sustainable. These challenges may in part explain the persis-
tence of medical inequity between developed and developing world, but it should 
by no means prevent the worldwide efforts to reduce it – may the present study 
thus join in the mission with its own little share.
Figure 1. climate map of Africa, sho-
wing location of Luanda (figure by 
author).
table 1. comparison of country profiles of the republic of Angola and Finland.5
Angola Finland
Population 19.1 million 5.3 million
Urbanized proportion of population 59% 85%
Life expectancy at birth 52 years 79 years
Under-five mortality rate 161/1000 3/1000
number of HiV-positive children (estimated) 22 000 -
conceptions affected by scd (estimated) 16/1000 -
Gross national income per capita 3 960 Us$ 47 170 Us$
General government expenditure on health 5.3% 11.7%
Proportion living under the international poverty line (1.25 Us$/day) 54% Unknown
Adult literacy rate 70% 100%
Luanda
Desert
Steppe
Rainforest
Savanna
Humid 
subtropical
maanantaina 16. syyskuuta 2013
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5. review of the literature
5.1 Otorhinolaryngological services, audiology, and research  
in resource-poor context
Even though the developing world stretches over virtually all the populated conti-
nents, the similar limitations in living conditions and health care systems in this vast 
area make the emerging ORL problems surprisingly similar. Therefore, in spite of 
the huge geographical, ethnic and cultural differences, it is no mere generalization 
to use as a common denominator “developing countries” for these regions. Typi-
cally, developing countries foster young, rapidly growing populations with broad 
ethnic and cultural diversity which suffer from high income inequalities. Domestic 
infrastructure, education, and manufacturing capacity seldom meet the demands 
of health care for these populations.6 In practice, the restricted resources are often 
directed toward the most severe and lethal conditions, whereas diseases leading 
to disability but only rarely to immediate mortality are left with little attention.7
The developing world is therefore characterized by a marked shortage of ORL 
services, personnel, and training opportunities. For example, in a survey covering 
18 African countries (not including Angola) with known public ORL services, the 
number of people per one ORL specialist ranged from 240 000 (South Africa) to 10 
million (Malawi), in comparison to the 1:100 000 in the UK, which, in fact, ranks 
at the bottom among Western countries.8
 Of these 18 African countries, 10 offered national ORL training, 2 had a trai-
ning program for audiologists, and 12 had no or very poor ORL services outside 
major cities. The availability of various services was zero or poor as follows: audio-
logy in 14 of the 18 participating countries, brainstem auditory-evoked potentials 
(BAEP) measurement in 16, hearing screening at schools in 15, hearing aids in 
16, bone-anchored hearing aids in 17, cochlear implants in all 18, myringotomies/
ventilation tubes in 14, tympanoplasty in 12, and mastoidectomy in 12. The authors 
concluded that in order to reach the lowest European level for ORL services, nearly 
4800 additional ORL specialists are required in sub-Saharan Africa, and proposed 
establishing a worldwide “Developing World Forum for ENT Surgery, Audiology, 
and Speech Therapy” to reinforce the clinical, teaching, and research resources in 
ORL in developing countries.1,2
Annually, nearly 800 000 babies (6/1000 live births) are born in developing 
countries are now suffering or eventually will suffer  from prelingual hearing loss.7,9 
By the age of nine, hearing loss prevalence will probably at least double.7 Roughly 
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half these cases are believed to be preventable, and otitis media emerges as a major 
avoidable etiology alongside meningitis, cerebral malaria, measles, and mumps.7,9,10 
Usually, public awareness of the signs, consequences, and rehabilitation of child-
hood hearing loss remains low, and, in the absence of widespread hearing scree-
ning programs, the handicap may lead to permanent limitations in their linguistic 
and educational development, economically burdening already poor societies.3,7,10 
Outside the Western countries, only China, India, and Botswana produce hearing 
aids locally; generally, retail prices of imported devices remain unaffordable for 
customers in developing countries.11
Nationwide, systematic hearing screening programs are lacking in developing 
countries. Regional neonatal hearing screening programs have recently been laun-
ched in some resource-restricted areas,12 but generally hearing-screening in deve-
loping countries relies on conventional audiometry typically performed in schools.9 
Simple low-cost, hand-held audiometers are available in developing-country set-
tings.9,10 In addition, screening  takes place in immunization clinics.13 
To save resources, screening has been targeted at known risk groups.12,14
Children at risk for hearing problems have also been identified by use of spe-
cific questionnaires on known risk factors and the guardian’s observations of the 
child’s speech development and response to sounds.15,16 Increasingly, physiological 
measurements such as BAEP and otoacoustic emissions have also become available 
in resource-restricted countries.17
In general, relatively few ORL studies have been conducted in developing count-
ries.  In the absence of local databases of childhood ORL diseases, large population-
based epidemiological surveys appear rarely and are available only from certain 
regions. Such reports typically concerned hearing loss and ear pathology in school-
children. No cohort-based studies exist. Epidemiological data on ORL diseases in 
younger children also prove difficult to find. Since long-term follow-up was typi-
cally impossible, prevalence rather than incidence rates were generally reported 
for ear and hearing pathology. Another type of report available was hospital-based, 
comprising retrospective chart-reviews and prospective studies, mainly conducted 
in tertiary referral centres of major cities where local ORL services exist. These 
studies therefore probably concerned the more severe and complicated cases, or 
cases occurring in generally ill children, because in developing countries medical 
aid for ORL diseases is often sought only as a last resort.   
5.2 Global burden of human rhino- and enteroviruses in  
respiratory infections
Human rhino- (HRV) and enteroviruses (HEV) are major pathogens in paediatric 
respiratory tract infections (RTI) in temperate climates of the northern hemisphe-
re.18-23 Being members of the Enterovirus genus and Picornaviridae family and thus 
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being only 30 nanometers in diameter, HRV and HEV carry single-stranded RNA 
inside an icosahedral, non-enveloped capsid consisting of four glycoproteins (VP1-
4).24-26 HRV is further classified into 3 (HRV-A, HRV-B, and HRV-C) and HEV into 
4 (HEV-A-D) species, comprising more than 100 HRV and HEV (sero)types.25,27
 The vast majority of HRV and several HEV types enter human cells through 
the intercellular adhesive molecule (ICAM-1) receptor25,28 in the oral mucosa or 
upper respiratory epithelium. HRV is transmitted through contact with contami-
nated hands or with inanimate surfaces,20,22,29 where it may persist for hours, even 
days.29,30 HRV and HEV may be identified by cell culture or reverse transcription 
polymerase chain reaction (PCR), the latter being superior in sensitivity.20,31
The clinical profile of HRV infection involves the typical common cold symptoms 
of rhinorrhea, sneezing, and cough, and appear either alone or in combination with 
bacteria, and also rhinosinusitis, otitis media, and pneumonia.22,24,27,32-34 In addi-
tion, HRV associates with asthma exacerbation in children.35,36 HRV, being acid-
sensitive, is unable to survive in the low gastric pH.20,22,27 Some recent data suggest 
that HRV-C may enter the circulation,37 but typical HRV infections are restricted 
to respiratory tissues. HEV also typically first invades the respiratory tissues, but, 
apart from common cold symptoms, it may equally likely cause gastroenteritis, 
“foot-and-mouth disease”, and severe, even fatal infections such as myocarditis 
and meningoencephalitis.24,38,39
 In a child living in a temperate climate, picornaviruses cause an estimated five 
symptomatic infections per year,40 and account for approximately half of the yea-
rly common cold episodes.31,40 Their incidence is, however, seasonal, with studies 
reporting proportions of 25 to 71% for HRV,18,19,23,32 and 10 to 18%18,23 for HEV in 
common colds. In temperate regions, HRV occurs throughout the year, but its inci-
dence tends to peak in autumn,40-44 and in some regions, also in spring.42-44 Factors 
contributing to increased HRV transmission include high relative humidity45,46 and 
crowding of children indoors during school terms.22,43
 In general, little data exist on the seasonality of HEV-caused common colds. 
HEV serotypes responsible for more severe diseases may either emerge in an epi-
demical pattern, prevail in summer-autumn, or express no clear seasonality,24,38 
and generally no seasonality have been recorded for common colds from HEV.41,47
 Data on common colds in tropical and subtropical climates are limited. Howe-
ver, the reported prevalences for HRV and HEV among children with respiratory 
symptoms range from 22 to 52% 48-51 and 3 to 15%49,50,52 among outpatients/follow-
up cohorts  (Table 2), and 6.5 to 41%48,53-55 and 4 to 20%53,54 among hospitalized 
children. In the tropics, HRV occurrence reportedly increases with humidity or 
rainfall53,54 and cooler temperatures,53 and HEV with dryness and hot temperature,54 
but several studies found no clear seasonality pattern for HRV48,49,55 or HEV.49,50,53,56
 Picornaviruses are highly associated with otitis media in children: HRV has oc-
curred in nasopharyngeal or middle ear samples of children with acute otitis media 
(AOM) in 20 to 41%18,41,57,58 and HEV in 6 to 25%.41,58,59 On the one hand, a follow-up 
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study of children under age two detected picornaviruses in MEE or nasopharyngeal 
samples of 54% of all children with AOM,41 while on the other hand, another stu-
dy showed that 30 to 34% of picornavirus colds were accompanied by AOM.18 No 
data emerged on otitis media in picornavirus colds in children in tropical climates.
5.3 Chronic suppurative otitis media in children of developing 
countries
5.3.1 EtiOlOGy, EpidEmiOlOGy, And mAnAGEmEnt OF ChrOniC Otitis  
mEdiA
Chronic suppurative otitis media (CSOM) is a persistent inflammation of the mucosa 
and submucosa of the middle-ear cleft which produces a suppurative discharge 
through a chronically perforated tympanic membrane (TM).10,60-63 The WHO de-
fines otorrhoea as chronic after it endures for at least 2 weeks,10 but no concerted 
opinion exists on the cut-off duration, and various values up to 3 months have 
been suggested.3,61,64 The bacterial etiology of CSOM, reflecting either primary in-
fection or secondary colonization, involves Staph.aureus and P.aeruginosa,10,60,65-69 
but children from a low-hygiene environment also exhibit enteric (e.g. E.coli) and 
low-virulence (e.g. Proteus) Gram-negative rods.60,70-73 In addition, anaerobes may 
contribute in up to 71% of cases.  
In the antibiotic era, CSOM has become a disease of the developing world. 
In addition, certain subpopulations in economically developed areas, such as the 
Inuits, South Pacific islanders, and Australian aboriginals, exhibit particularly high 
CSOM prevalences: up to at least 15%.74-78 The vast majority, approximately 85 to 
90%, of the global CSOM burden lies on Asia and South Pacific, mainly due to the 
large population of these areas, whereas the continent of Africa constitutes 4 to 8% 
of the cases worldwide. The WHO classifies CSOM prevalences as the following: 
the lowest <1%, low 1 to 2%, high 2 to 4%, and highest >4%; with prevalences ex-
ceeding 2% demanding urgent attention and >4% representing “a massive public 
health problem”.10 Sub-Saharan Africa has reported prevalences of 1.1 to 4.6%,10,79-82 
table 2. Human rhinovirus (HeV) and human enterovirus (HeV) in paediatric outpatients of subtropical/
tropical low-resource countries in the polymerase chain reaction era.
Country, year n Age (years) sampling method hrV (%) hEV (%)
mozambique 2011 49 333 0–1 nPA 26 3
Kenya 2012 48 254 0–12 nPA 22 unmeasured
Kenya 2010 51 197 5–10 nPs 26.4 unmeasured
senegal 2010 220 82 0–5 nPs 9.7 0
nPA, nasopharyngeal aspirate 
nPs, nasopharyngeal swab
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contrasted with the European WHO estimate of 0.4%.10 In Angola, in the 1980’s, 
chronic otitis media occurred in 3.4% of schoolchildren.79 Despite its relatively low 
global share in CSOM cases, of all deaths due to otitis media complications in 2008, 
Africa accounted for two-thirds.83
 Approximately one-fifth of the CSOM cases occur in children less than age 5.84 
Risk factors for chronic otorrhea include poor socio-economic status, crowding, 
malnutrition, short duration of breastfeeding, parental smoking, and lack of clean 
water for washing.72,75,77,78,82,85 In resource-poor settings, deficiencies in vitamin A 
and zinc may also add to the risk for a chronic or more severe course of otitis me-
dia.86-88 In addition to the living conditions and environmental variables, genetic 
factors predispose to chronic otitis through anatomical (e.g. short auditory tube)60,63 
and functional (e.g. epithelial ciliary motility) variance60 (Figure 2). 
In general, few data exist on treatment of paediatric CSOM in developing count-
ries. The strongest evidence concerns the resolution of otorrhea, while in the lack 
of long-term follow-up, data on recurrence, restoration of the tympanic membrane 
and hearing, complications, and adverse effects of the treatment remain uncertain.89 
However, the safety of topical ofloxacin is evident in children.90 
In resource-poor settings, the treatment is based on regular ear cleansing, which 
in itself has no therapeutic efficacy,91 but facilitates the entry of topical antimicro-
bials into the middle ear.92 Clinical trials have shown the efficacy of ototopical an-
Figure 2. risk factors, features, and events contributing to progression of otitis media towards chronic and 
complicated forms in children of developing countries.
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tibiotics in treating CSOM in children;89 at least ofloxacin,70,91,93 ciprofloxacin,68,94 
and neomycin-polymyxin-B93 have been studied in low-resource settings. Other 
topical antibiotics in clinical use include gentamycin, tobramycin, chloramphenicol, 
trimethoprim, and erythromycin.10 Adding systemic antibiotics to local treatment 
is not recommended due to its lack of efficacy and low cost-effectiveness.10 Topical 
antiseptics, such as boric acid, are cheap and useful,95 but remain less efficacious 
and may cause more local irritation than a local antibiotic would.94
5.3.2 COursE And COnsEquEnCEs OF ChrOniC Otitis mEdiA
Generally, CSOM is regarded as forming a continuum with AOM and otitis media 
with effusion,60,61,63 and in developing countries it is mostly believed to arise from 
an unresolved or untreated AOM episode, whereas traumatic TM perforations may 
play a lesser role.3,10,63,96 In industrialized countries, CSOM usually associates with 
tympanostomy tubes. 97,69,98,99 In otitis-prone children, early bacterial colonization, 
leading to formation of biofilms and chronic inflammation in the nasopharynx 
and auditory tube, may contribute to the persistence of middle-ear infections.100,101
Prolonged inflammation of the middle-ear cavity induces changes in the sur-
rounding structures that complicate treatment attempts and the healing process. 
In the mucosal lining, metaplasia occurs, and mucus-producing glandules, as well 
as ciliated cells and highly vascular granulation tissue emerge. Ongoing infection 
may also invade the underlying bone, causing osteitis and reactive osteogenesis. 
Pathological changes detectable in TM include fibrosis, thickening, retraction, epit-
helialization, and myringitis that may lead to polyp formation. Cholesteatoma may 
also occur.10,61,62,102,103
 CSOM may lead to conductive hearing loss resulting from the discharge in the 
ear canal. Thickening, retraction, and perforation of the eardrum also produce con-
ductive hearing loss.3,61 In addition, resorption and disruption of the ossicular chain, 
in 11 to 68% of patients of various ages discovered during surgical treatment,104-106 
may worsen hearing loss. Bacterial toxins may also enter the inner ear through the 
round window membrane, causing cochlear damage and a sensorineural or mixed 
type of hearing loss.107-109 Another risk factor for cochlear hearing loss is ototoxicity 
from topical aminoglycosides, which are usually preferred to the safer but more 
expensive quinolones in lower-resource health care.3 However, ototoxicity may not 
be very usual in clinical settings.110
Apart from hearing loss, CSOM may lead to suppurative complications that 
can be extracranial, such as labyrinthitis, mastoiditis/mastoid abscess, petrositis 
or facial paralysis; or intracranial, such as thrombosis of lateral or cavernous sinus, 
meningitis, cerebellitis, epidural/subdural/cerebral abscess, hydrocephalus, and 
labyrinth sclerosis. These intracranial complications hold the main responsibility 
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for CSOM-associated mortality, which in Africa has been estimated by the WHO 
to reach 1.8%.10,84,102,103,111,112
 In sub-Saharan Africa, up to 3100 children under 15 thus far have died annually 
in the 2000’s due to complications of otitis media.84 Even though severe complica-
tions of CSOM have been estimated to be relatively rare in children,10 their risk is 
significantly higher than for adults84,111 Among CSOM patients presenting at ORL 
clinics in Africa, subperiosteal abscesses and intracranial complications have been 
reported in 6 to 11%.103,111,112 Apart from mortality, complications of CSOM may lead 
to severe permanent neurological sequelae.10
In Thailand, 102 (0.59%) complications occurred in 17 144 otitis media cases seen 
in health care settings in the 1980’s, and the majority of them arose from CSOM. 
In that series, the most frequent extracranial manifestations were facial paralysis, 
subperiosteal abscess, and labyrinthitis, whereas the intracranial complications were 
mainly meningitis and intracranial abscess, leading to death in 18.6%.113
 However, chronic suppuration may also spontaneously resolve, followed by 
healing of the perforation or by chronic perforation with either no or only an oc-
casional discharge.63 In follow-up of CSOM children without therapy, suppuration 
had ceased at 6 weeks in 18%72 and at 16 weeks in 22%91; and only 13% had intact 
TMs at 16 weeks.91
 Of the worldwide otitis media-related hearing loss, 90% occurs in develo-
ping countries, where CSOM appears a major cause for acquired hearing loss in 
children.3,80,96,114 Among paediatric CSOM patients, hearing loss has been docu-
mented in 47 to 96%,80-82,114-116 and mainly presents as slight or moderate.68,81,82,114 
CSOM affects most heavily young children,3,72,85,112,115 and may endanger their lan-
guage acquisition, social development, and scholastic performance.75,82,117
5.4 Otorhinolaryngological signs and complications of sickle-cell 
disease
5.4.1 EpidEmiOlOGy, pAthOphysiOlOGy, And mAnAGEmEnt OF siCklE-CEll 
disEAsE
Sickle-cell disease (SCD) is the most prevalent monogenic disease worldwide, with 
300 000 affected children being born every year.118 Of the patients, the developing 
countries have at least 80%.119 In Sub-Saharan Africa, 180 000 births occur an-
nually, and due to improved patient survival, the burden of disease in this area is 
increasing.119 Given survival rates half the local average, six million SCD patients 
will live in the area.120  The generally healthy carriers of the sickle-cell mutation, 
“trait”, appear to be nearly 90% protected against severe Plasmodium falciparum 
malaria,121 and the malaria-endemic regions of Arabia, Mediterranean, India, and 
Africa thus experience the highest SCD incidence.120,122-124
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 In Africa, the top SCD rates occur between 15° north and 20° south latitudes 
where up to 40% of the population may carry the sickle-cell trait.125 In Angola, SCD 
affects 1.6% of conceptions,123 which may exceed the actual proportion of newborns, 
because  SCD adversely affects fetal survival.126
SCD is a haemoglobin disorder resulting from coinheritance of the “sickle” al-
lele, HbS, and another mutant haemoglobin allele; either a second HbS resulting 
in the homozygous HbSS disease called sickle-cell anemia, or another type of a 
mutant allele, such as HbC or thalassemia, resulting in compound heterozygous 
inheritance.120,124,127 In sub-Saharan Africa, the HbSS genotype prevails, with only 
small minorities of HbSC and other types.122,125
 The sickle haemoglobin contains a single amino acid substitution (valine for 
glutamic acid) in its β-chains, leading to loss of form and function of the red blood 
cells (Figure 3), chronic haemolytic anemia, and acute vaso-occlusive crises, as well 
as various systemic outcomes related to haemolysis and tissue infarctation.124,127 
Through vaso-occlusive congestion, repeated splenic infarcts, and fibrosis, SCD 
leads to functional hyposplenism,128 which makes the children highly susceptible to 
severe bacterial infections, particularly by Streptococcus pneumoniae,123,129-132 which 
markedly contributes to the estimated 50 to 90% mortality among affected African 
children.122,133,134 In addition to the genetic factors, environment plays a marked role 
in the phenotype of SCD patients,135 and a paucity of data exists on the complica-
tions and natural course of SCD in developing countries.119
Figure 3. Abnormally shaped erythrocytes in sickle-cell disease (figure provided by specialist in clinical 
chemistry Päivi Helminen-Pacius from HUsLAB laboratory, Helsinki University central Hospital, Finland).
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table 3. Hearing loss exceeding 25 dB HL in audiometry, and related middle-ear pathology (meP) in 
children with sickle-cell disease. Adapted from: taipale A, Pelkonen t, Bernardino L, Peltola H, Pitkäranta 
A. Hearing loss in children with sickle-cell disease. Pediatrics International 2012; 854-857. © the Authors. 
Pediatrics international © 2012 Japan Pediatric society.
Author, country n Age (years)
hearing loss proportion 
of mEp in 
hearing lossn (%) bilateral
Alabi et al., 2008 (139) 
 nigeria
80 4–15 25 (31%) 22 28%a
odetoyinbo and Adekile, 1987 (144)
 nigeria
56 6–15 12 (21%) 7 0%
mgbor and emodi, 2004 (143) 
 nigeria
52 6–19 7 (13%) 7 no mention
de castro silva et al., 2010 (140) 
 Brazil
40 8–20 11 (28%)a 5 0%
tsibulevskaya et al., 1996 (138) 
 Kenya
33 7–14 12 (36%) 2 0%
macdonald et al., 1999  (149)  
 UsA
84 8 months – 24 yrs 26%c nm 23%a
Forman-Franco et al., 1982 (141) 
 UsA
54 12 (mean) 11% nm 7%
a middle-ear effusion 
b Hearing loss exceeding 20 dB, measured by brainstem auditory-evoked potentials 
c neither number of children with nor definition of hearing loss mentioned
Successful management of SCD is possible in resource-poor settings and includes 
a balanced diet with folic acid supplement, avoidance of extreme physical stress, heat, 
and dehydration, treatment with penicillin prophylaxis, pneumococcal vaccinations, 
analgetics, hydroxyurea, and blood transfusions.118,125,136 Newborn screening, not yet 
usual in developing countries, is necessary for early identification and management 
of new SCD children,137 and has the potential to reduce SCD mortality.138
5.4.2 hEArinG lOss in siCklE-CEll disEAsE
SCD is known to associate with sensorineural hearing loss in children,139-144 ado-
lescents,140,141,143-149 and adults.146-152 Hearing loss has been proposed to relate to 
cochlear ischaemia, based on post-mortem observations of the temporal bones 
of an SCD child with known hearing loss.153 Corroborating this theory are case re-
ports of adolescents with reversible hearing loss in association with vaso-occlusive 
crisis.141,154 Other support for hypoxia in the pathogenesis of SCD-related hearing 
loss include the high dependency of cochlear homeostasis on its vascular supply, 
inner-ear vascularization deriving exclusively from the internal auditory artery, 
and the degeneration and ossification in the cochlea after internal auditory artery 
occlusion.155  In one SCD child, labyrinthitis ossificans has been a cause of prog-
ressive sensorineural hearing loss.156
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  Hearing loss of varying definitions has occurred in SCD children/adolescents at 
a rate of 3.5 to 12% in developed countries.142,157-159 In developing countries, conduc-
tive or sensorineural bilateral hearing loss exceeding 25 dB HL has been reported in 
6 to 27.3% of mainly school-aged children (Table 3). Some studies have perceived 
higher prevalences of hearing loss in older patients.147,148,150,152,160 The SCD-related 
hearing loss has been reported to involve either exclusively high,145,147-149,160 or all142-
144,146,154,160,161 frequencies, with both sudden141,154 and slow145,147 onset. The sudden-
onset hearing loss may relate to an acute vaso-occlusive event in the cochlea,141,154 
whereas the slow-onset type may result from anoxia of the hair cells produced by 
non-acute erythrocyte sickling and chronically impaired local oxygen balance.162   
5.4.3 OthEr OtOrhinOlArynGOlOGiCAl mAniFEstAtiOns in siCklE-CEll 
disEAsE
The ORL manifestations of SCD remain poorly described in children. The estimation 
is that unvaccinated SCD children without prophylactic penicillin may experience 
a 33- to 100-fold123,132,163 risk for invasive pneumococcal infections. Streptococcus 
pneumoniae frequently causes otitis media, which is, in contrast, usually a localized 
infection, and no studies have been aimed at defining the incidence or prevalen-
ce of otitis media in SCD children. However, antibody-deficient children without 
haemoglobin disorders do suffer from recurrent and persistent ear infections.164,165 
SCD-related ORL findings, mainly described in case reports, include bone in-
farcts, osteonecrosis, osteomyelitis, extramedullary hematopoiesis in the paranasal 
sinuses, bone marrow hyperplasia of the maxilla and skull base, soft-tissue abs-
cesses, and cervical lymphadenopathy.166-169 Adenoid hypertrophy170,171 and nasal 
obstruction resulting from turbinate congestion170 may also occur in children. In the 
absence of prospective follow-up studies, the frequencies of various manifestations 
remain, however, unknown.
5.5 Otorhinolaryngological pathology in human immunodeficiency 
virus –infected children
5.5.1 pAthOphysiOlOGy, EpidEmiOlOGy, And mAnAGEmEnt OF humAn im-
munOdEFiCiEnCy Virus inFECtiOn
Human immunodeficiency virus (HIV) is an enveloped, single-stranded RNA retro-
virus in the Lentivirus genus of the Retroviridae family. With the aid of its external 
gp120 glycoprotein, HIV enters CD4 (cluster of differentiation 4) glycoprotein-
expressing human cells, e.g. helper T cells, monocytes, macrophages, and glia cells. 
Initial infection occurs through percutaneous or mucous membrane contact with 
contaminated objects or body fluids, as well as transplacentally in utero. Untreated 
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infection leads to deterioration of the host’s immune system, subsequent severe 
bacterial and viral infections, diseases by opportunistic microorganisms (candida, 
Pneumocystis jirovecii, Cryptococcus, mycobacteria), occurrence of malignancies, 
general wasting, and, finally, death.172
 In resource-poor countries where children are usually infected intrauterinally, 
perinatally, or via breastfeeding, roughly half the untreated children progress to 
death within the first 2  years of life,173,174 while the rest appear to be slow progressors 
with a median survival of 6 years, or long-term survivors with several asymptomatic 
years.172 Paediatric HIV is mainly being caused by the viral subtype HIV-1, whereas 
HIV-2 is of West African origin and occurs rarely in children.175
Worldwide, sub-Saharan Africa carries the heaviest burden of HIV. In 2009, 
2.3 million HIV-positive children lived in the area, constituting more than 90% of 
table 4. World Health organization clinical stages of human immunodeficiency virus (HiV) infection.177 
Clinical stage General findings Otorhinolaryngological findings
i – Asymptomatic •	Persistent generalized 
lymphadenopathy
•	Persistent cervical 
lymphadenopathy
ii – mild •	Herpes zoster                                     
•	Papular or seborrhoeic dermatitis     
•	extensive wart virus or molluscum  
contagiosum infection                              
•	Persistent hepatosplenomegaly
•	recurrent sinusitis, tonsillitis, otitis 
media, pharyngitis           
•	Angular cheilitis                        
•	Lineal gingival erythema           
•	recurrent oral ulceration           
•	Persistent parotid enlargement
iii – Advanced •	moderate malnutrition or wasting
•	Persistent fever or diarrhoea                         
•	Pulmonary or lymphatic 
tuberculosis
•	recurrent bacterial pneumonia     
•	chronic HiV-associated lung 
disease
•	Anaemia, neutropaenia, or chronic 
thrombocytopaenia
•	Acute necrotizing stomatitis or 
gingivitis                                     
•	Persistent oral candidiasis        
•	oral hairy leukoplakia              
•	cervical lymph node tuberculosis
iV – severe •	severe malnutrition, stunting or 
wasting
•	chronic cryptosporidiosis, 
isosporiasis, or herpes simplex 
infection
•	recurrent severe bacterial 
infection
•	Pneumocystis jirovecii pneumonia      
•	Atypical mycobacteriosis, 
extrapulmonary tuberculosis or 
cryptococcosis, disseminated 
mycosis
•	HiV encephalopathy
•	Kaposi sarcoma, non-Hodgkin 
lymphoma
•	chronic herpes simplex infection 
(orolabial)                    
•	oesophageal candidiasis           
•	Kaposi sarcoma (oropharyngeal, 
intraparotid)                          
•	non-Hodgkin lymphoma (intraoral, 
cervical)
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all paediatric HIV cases. Both the incidence of and mortality from paediatric HIV 
declined slightly in the area during the 2000’s, resulting in a net increase in the 
number of children living with HIV. In fact, two-thirds of the world’s HIV patients 
live in the area of 10 sub-Saharan countries including Angola. The number of An-
golan HIV-positive children reached 22 000 in 2009, at a time when only some 
15% of these children received antiretroviral therapy.176
In children at least 18 months old, HIV may be diagnosed serologically, whe-
reas – due to the persistence of maternal antibodies a definite diagnosis in younger 
children requires virological tests.177 A positive serological test in an infant, howe-
ver. reveals exposure to HIV.178 In low-resource health care, where the availability 
of virological testing is constrained, clinical signs178 or other parameters179 may be 
necessary to predict the HIV status of the infant. In developed countries, HIV sta-
ging is based on viral PCR and CD4 T cell counts, which are however not always 
available in resource-poor settings. Therefore, based on clinical signs, WHO has 
staged the severity of HIV infection in four categories (Table 4).177
Medical management of HIV infection is based on combination therapy with 
antiretroviral drugs, called, by their mechanism of action, nucleoside and non-
nucleoside reverse-transcriptase inhibitors, and protease inhibitors. In children 
under age 2, antiretrovirals should be started promptly after diagnosis, whereas 
in older children, the beginning of treatment should be guided by CD4 counts.178 
Zidovudine prophylaxis in the newborn has been used for prevention of intrapar-
table 5. Percentages of otorhinolaryngological findings in representative studies in HiV-positive children. 
Adapted from: springer and European Archives of Oto-Rhino-Laryngology, volume 268 (2011), p.1527-1532. 
otorhinolaryngological findings in Human immunodeficiency virus-positive and –negative children in a 
developing country. taipale A, Pelkonen t, taipale m, roine i, Bernardino L, Peltola H, Pitkäranta A., table 
4; with kind permission from springer science and Business media.  
Author, country n Cervical 
lymphadeno-pathy
Eczema Chronic 
Om
parotid 
hyper-
trophy
Oral 
candidiasis
Any Orlb 
pathology
chaloryoo et al.  
 (1998) 186 
 thailand 
250 42 23 18 5 60 nmc
Gondim et al.                 
 (2000) 188  
 Brazil  
20a 60 nm 15 25 35 90
Hadfield et al.                
 (1996) 185           
 UK
66 71 15 8 14 33 91
singh et al.                        
 (2003) 184      
 UK             
107 36 nm nm 6 18 50
om, otitis media 
orL, otorhinolaryngological 
nm, not mentioned 
a mean age 3.8 years
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tum HIV transmission, but a two- or three-drug regimen has proven more effica-
cious if the mother has not received antepartum antiretroviral therapy.180 However, 
in low-income settings, limitations in infrastructure, drug availability, monitoring 
resources, and treatment adherence challenge HIV prevention and management.175 
5.5.2 OtOrhinOlArynGOlOGiCAl AspECts OF humAn immunOdEFiCiEnCy 
Virus inFECtiOn
Worldwide, more than 90% of newly infected HIV children live in sub-Saharan 
Africa,176 and at least 22 000 HIV-infected children live in Angola.181 Paediatric HIV 
manifests in ORL area in multiple ways182-189 and in up to 91% of the infected;184,185,188 
often already during the first years of life.188 Table 5 summarizes previously docu-
mented frequencies of common ORL findings among HIV-positive children of deve-
loping countries, and Table 4 presents the ORL aspects of the HIV staging system. 
In addition to the manifestations mentioned in these tables, marked adenotonsillar 
enlargement may occur in HIV children,182 as well as initial hypertrophy followed 
by end-stage atrophy.190 
Hearing loss has been reported in HIV-positive children in 27.5 to 38.8%,191-194 
and sensorineural hearing loss in 7.1 to 16.7%.192-194 Possible causes for sensorineural 
hearing loss in HIV patients include ototoxicity from antiretroviral therapy (mainly 
nucleoside analogues, as reported in adults), antituberculotic medication (strepto-
mysin),195,196 aminoglycosides,195,197,198 or possibly the direct neurotoxic effects of the 
HIV infection itself.192-194 In addition, cytomegalovirus and Cryptococcus infections 
have induced hearing loss in HIV-positive adults,199,200 with no reports in children. 
Despite the possible presence of cochlear and neural lesions from these causes, 
however, a major contributor in HIV-positive children’s hearing problems is otitis 
media, which strongly associates with HIV both in developed187,201-203 and in de-
veloping191,204-206 countries. The severity of immunodeficiency may correlate with a 
tendency for chronic204,207 or recurrent202,203 otitis media. In African HIV-infected 
children seen at hospital, 4 to 20% have presented with otorrhea,206,208,209 which 
usually involves bacteria typical of CSOM in developing countries.186,210 HIV-infected 
children are also subject to complications of otitis media.187
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6. aims of the study
The primary aim of the present study was to collect epidemiological and clinical data 
on paediatric ORL findings in Luanda, Angola. The specific aims were to assess: 
• the prevalence of and clinical findings concerning human rhino- and ente-
rovirus positivity during the cool season;
• CSOM-related background characteristics, bacteriology, and hearing; 
• ORL status and hearing in SCD patients;
• HIV-associated ORL findings and hearing.  
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7. children and methods
7.1 study groups and laboratory methods
The study data were collected in the Paediatric Hospital of Luanda (Hospital Pediát-
rico David Bernardino), a university teaching hospital, in January-July 2008. The 
Paediatric Hospital’s ethics committee gave approval for the study on December 
27th 2007. The study children were recruited among voluntary outpatients of the 
Paediatric Hospital’s different polyclinics (pulmonology, surgery, general pediat-
rics, neurology, HIV, sickle-cell disease, gastroenterology, infectious diseases). In 
addition, a few accompanying siblings of the patients were included. At the general 
enrollment desk for all clinic outpatients, the receiving secretary provided basic 
information on the study and offered the opportunity for everybody to participate. 
Children with ear discharge, as well as outpatients of the HIV and SCD clinics were 
addressed in particular. In addition, a local nurse who served as a study assistant 
helped in the recruitment. All volunteering children were primarily accepted, and 
the children or their guardians then received more specific oral information on the 
aims and procedures of the study from the examining doctor prior to giving their 
oral consent.  
During the study period, data came from a total of 406 children. All children 
meeting the inclusion criteria for Studies I to IV were then extracted from this 
data pool. In Studies II to IV, the age- and gender-matched controls for the patient 
groups were randomly selected among the remaining data pool. The control groups 
in Studies III and IV therefore included 29 children in common. 
For Study I, 102 children displaying symptoms of the common cold (rhinorr-
hoea or cough, with or without fever) were recruited during April-July. Of these 
children, 79 were participants from Studies II to IV: 65 patients from Studies II to 
IV and 14 controls from Studies III and IV. 
In Study I, a nasopharyngeal smear (NPS) was obtained with a sterile cotton 
swab from each of the 102 participants. The NPS specimens were preserved fro-
zen, transported to Helsinki, Finland, and analyzed for HRV and HEV by real-time 
PCR assay. The analysis for HRV was performed as described earlier,211 applying 
the cut-off threshold of 8% of the strongest positive control. The analysis for HEV 
was performed according to the method by the US Centers for Disease Control and 
Prevention, Atlanta, Georgia, USA212 applying the cut-off threshold of 10% of the 
strongest positive control.  The real-time-PCR analyses were executed at Finland’s 
National Institute of Health and Welfare.  
Study II comprised 23 children with CSOM and 23 age- and gender-matched 
controls without ear complaints or TM perforations. The CSOM group comprised 
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children with purulent middle-ear discharge for at least 2 months. Bacterial smears 
from the discharging ears – or in bilateral cases, from the more profusely discharging 
ears – were taken with a sterile cotton swab and cultured under aerobic conditions 
according to the norms of the National Committee for Clinical Laboratory Standards. 
For Study III, 61 children with SCD from the SCD outpatient clinic were recruited; 
61 age- and gender-matched children without clinical suspicion of SCD, known 
sickle cell trait, or a previous cerebral infection served as controls. SCD diagnosis 
was based on haemoglobin electrophoresis. The controls did not routinely undergo 
haemoglobin analysis.
Study IV comprised 78 HIV-positive outpatients from the HIV polyclinic, and 
an age- and gender-matched group of 78 controls without clinical suspicion of 
HIV. HIV was diagnosed with a specific antibody-detection test (Hexagon HIV® 
Human, Wiesbaden, Germany). The HIV negativity of the controls was not sero-
logically verified. 
7.2 interview and physical examination
All study participants, together with their guardians, underwent a structured inter-
view concerning the child’s living conditions and family size, medical history and 
vaccinations, intake of medication, and ear- and hearing complaints. Subsequently, a 
basic physical examination and a thorough ORL status were performed (Appendix). 
The children’s linguistic development was assessed in a free conversation with the 
child; especially with the youngest children, assessment was based on information 
from the guardian.
The basic physical examination comprised an overall assessment of the child’s 
general condition, measurement of weight and height, cardiac and pulmonary aus-
cultation, and palpation of the abdomen. In addition, the inguinal and axillar lymph 
nodes were palpated and dermal abnormalities registered. The children’s nutritional 
status was assessed by the WHO standards for weight for age, and children with a 
low weight for age (below -2 SD or the 3rd percentile) were considered malnourished. 
Pneumonia was diagnosed in children with fever, cough, and tachypnea, augmented 
by pulmonary auscultation and, when available, chest x-rays.213,214 The guardian 
or the examining doctor assessed the child’s feverishness without a thermometer. 
The HIV-positive children who presented with clinical signs of WHO disease-stage 
III or IV177 (Table 4) were considered as having an advanced state of the disease.
7.3 Otorhinolaryngological examination
All study children underwent a thorough ORL examination including anterior 
rhinoscopy, oral and oropharyngeal cavity examination, pneumatic otoscopy, and 
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tympanometry. Any facial abnormalities were visually assessed, and the size and 
appearance of aurices, as well as possible existence of preaurical fistules, were re-
corded. In addition, the cervical area was palpated, and the size (cm) and location of 
palpable lymph nodes or tumors were recorded, as well as the size and consistency 
of the salivary glands.
The oral and oropharyngeal examination included the oral mucosa, tonsils, and 
the dental status. Absence of teeth was noted, as well as abnormal development, 
and presence of cariotic lesions in the dentition.  Tonsillar size was graded on the 
basis of Mallampati classification 0-4 (0: tonsils fit within the tonsillar fossa; 1: 
tonsils 0 to 25% of the space between the pillars; 2: tonsils 25 to 50% of the space 
between the pillars; 3: tonsils 50 to 75% of the space between the pillars; 4: tonsils 
75 to 100% of the space between the pillars).
Otologic assessment comprised pneumatic otoscopy and tympanometry. During 
otoscopy, the ear canal was cleansed from cerumen or suppuration with cotton sw-
abs and alligator forceps. However, if a satisfactory view of the tympanic membrane 
was impossible due to tightly impacted cerumen or excessive suppuration, the case 
was simply defined as “cerumen impaction” or “suppuration.” Diagnosis of AOM 
was based on detection of middle-ear fluid behind an inflamed TM, accompanied 
by any sign of local or general infection. Signs of fluid in the middle ear comprised 
visible fluid or pus behind the TM, flatness or bulging of the TM, restricted mobility 
of the TM. Inflamed TMs were red, yellow, or opaque. Local and general signs of 
infection included earache, fever, rhinorrhea, cough, and vomiting. Children with 
fluid in the middle ear but without inflamed TMs and evidence of an acute infection 
were defined as having middle-ear effusion (MEE). Suppurative discharge from the 
middle ear enduring for less than 2 months was also defined as AOM. Suppuration 
persisting for over 2 months was defined as CSOM.
Tympanometry was performed with a GSI 38 Auto Tymp tympanometer (Gra-
son-Stadler, Inc., Eden Prairie, MN, USA). A pressure range of -400 to +200 daPa 
was tested with a 226-Hz probe. The tympanograms obtained were classified as 
A, B, and C according to the presence and location of the peak on the horizontal 
axis (daPa). (Figures 4 a-c)  Curve gradients were not accounted for. Curves with 
a distinct peak at -150 to +100 daPa were designated as type A, which suggested 
normal pressure in the middle ear. Curves with a peak occurring at -400 to -150 
daPA were designated as type C, and suggested possible negative pressure in the 
middle ear. Both types A and C were interpreted as indicating an intact TM without 
fluid in the middle ear. Peakless curves were designated as type B and considered 
to suggest either fluid in the middle ear, TM perforation, or cerumen impaction. 
The final assessment of middle-ear status was based on both tympanometry 
and otoscopy. However, even if nonremovable cerumen prevented a view of the 
TM with an otoscope, obtaining a type A or C tympanogram was considered as 
ruling out TM perforation.         
32
Children and methods
7.4 hearing measurements
Hearing measurements comprised BAEP threshold screening (Bera MADSEN Oc-
tavus® system v.2.001, Windows XP/2000 compatible; GN Otometrics, Taastrup, 
Denmark), and air-conduction pure-tone audiometry  (Midimate 622 Clinical/
Diagnostic Audiometer; Madsen Electronics, Taastrup, Denmark). Click-stimulated 
BAEP screening was applied in all children. Pure-tone audiometry was measured 
without a masking tone. Audiometry was performed in children of at least 5 years 
of age, due to its cognitive and co-operative requirements.
In pure-tone audiometry, hearing was tested at 0.125, 0.25, 0.5, 1, 2, 4, 6, and 
8 kHz (Figure 5). Starting from 1 kHz, the higher frequencies were tested first in 
ascending order, followed by the lower frequencies in descending order. At each 
frequency, the screening level was 20 dB HL. If the child failed to respond at 20 
dB HL, the sound level was increased by 5 dB until a response was obtained. If 
the result at any frequency was assessed as unreliable, the hearing threshold was 
confirmed by immediate re-testing. Pure-tone averages (PTA), the mean hearing 
thresholds of 0.5, 1, 2, and 4 kHz, were applied in Studies II and IV, whereas in 
Study IV each frequency in the range 0.25 to 8 kHz was analyzed separately. The 
hearing thresholds were graded according to the WHO scale (Table 6).215 Whi-
le performing pure-tone audiometry, the researchers continuously assessed the 
surrounding noise level. In the absence of sound-proof facilities, all sounds from 
inside the examination room, such as air-conditioning, were quieted, and during 
any noise from outside the room, the screening was paused. 
BAEP thresholds were measured at 40, 60, and 80 dB, (Figure 6) and the re-
sults interpreted as follows: absence of a normal response at 40 dB was considered 
a moderate hearing loss; absence of a response at 40 and 60 dB a severe hearing 
loss; and an absent response at all three levels a profound hearing loss. 
Figures 4a-c. examples of tympanogram curve types A-c. ecV – external canal volume, normally in children 
approximately 0.6 cm3; Gr – tympanogram gradient, width of graph at 50% of the maximal admittance; 
PeAK – the maximal (static) admittance of tympanic membrane. 
a: type A – graph with a distinct peak occurring at a pressure higher than -150 daPa (on x axis).  
b: type B – flat graph with no detectable peak.  
c: type c – graph with a distinct peak at a pressure less than -150 daPa.  
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The BAEP screening was performed without sedation and under the supervi-
sion of at least one of the researchers. Older children were seated on a chair and 
those younger in their guardian’s lap. Attempts were made to keep each child’s 
movements, especially eye movements, to the minimum, and the youngest children 
Figure 5. Pure-tone audiometry measured in children aged 5 and above.
table 6. WHo hearing impairment grades, definitions, and recommendations.217 
Grade of hearing impairmenta Clinical hearing recommendations
slight (26–40 dB HL) normal voice at a distance of 
1 metre
counselling; hearing aids 
recommended for children 
with thresholds > 30dB
moderate (41–60 dB HL) raised voice at a distance of 
1 metre
Hearing aids recommended
severe (61–80 dB HL) some words when shouted 
into better ear
Hearing aids; if not available, 
signing and lip-reading 
necessary
Profound or deaf (≥81 dB HL) Unable to understand even 
with shouting into ear
Hearing aids may prove 
useful; lip-reading, signing, 
additional rehabilitation 
essential
a defined as the average pure-tone threshold of 0.5, 1, 2 and 4 kHz in the better ear.
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Children and methods
were calmed by breastfeeding. After the skin was first carefully dried from sweat, 
the electrodes were positioned on the anterior forehead and at the mastoids. In the 
case of excessive artefacts in the response curve, the measurement was temporarily 
paused until the artefact source was neutralized.     
7.5 statistical analysis
Statistical analyses of the data were performed with Statview® (v.5.0.1, SAS Institute 
Inc., Cary, NC, USA). Statistical correlations for nominal variables were analyzed 
with Pearson’s chi-square and Fisher’s exact tests, whichever was feasible. Medians 
of continuous variables were compared with Mann-Whitney’s U-test. Resulting p 
values ≤ 0.05 were considered statistically significant.
Figure 6. Brainstem auditory-evoked  
potentials registered without sedation.
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8. results
8.1 respiratory infections – virology and clinical profiles [i]
In this study, of 102 NPS specimens, 37 (36%) appeared positive in PCR: 27 (26%) 
for HRV alone, 3 (3%) for HEV alone, and 7 (7%) for both viruses. In comparison 
of the virus-positive and -negative children, the virus-positive children were signifi-
cantly younger (36 months vs. 52 months; p=0.024). Chronic illnesses (HIV, SCD, 
tuberculosis) were present in 70% (26/37) of the PCR-positive vs. 63% (41/65) of the 
PCR-negative children (p=0.604), and malnourishment in 19% vs. 31% (p=0.218). 
No statistically significant differences emerged in frequencies of clinical findings 
among the PCR-positive vs. PCR-negative children with common colds: feverishness 
[12 (30%) vs. 13 (20%); p=0.161], rhinorrhea [25 (68%) vs. 35 (54%); p=0.176], 
cough [22 (59%) vs. 28 (43%); p=0.112], AOM [9 (24%) vs. 8 (12%); p=0.117], 
pneumonia [6 (16%) vs. 6 (9%); p=0.292]. Neither did other clinical findings, such 
as wheezing, postnasal drip, tonsillitis, hoarseness, or conjunctivitis, associate with 
the PCR outcome, and these findings occurred in only a few children. Five of the 
six picornaviral cold-associated pneumonias occurred in HIV-positive children.
Both the occurrence throughout the study of common colds and the proportion 
of HRV-positive specimens increased, HRV presenting  in 47% (25/53) of the spe-
cimens taken in the coolest month, July, vs. 18% (9/49) in April to June combined 
(p=0.021; Figure 7). 
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Figure 7. emergence of  human rhinovirus (HrV) and  human enterovirus (HeV) in polymerase chain reaction 
in nasopharyngeal smears of paediatric outpatients with respiratory symptoms during 4 autumn-winter 
months in Luanda, Angola. the monthly mean temperatures (left vertical axis) and air humidity values 
(right vertical axis) are long-term averages in Luanda. (216) Adapted from: taipale A, Pelkonen t, roivainen 
m, Kaijalainen s, Bernardino L, Peltola H, Pitkäranta A. Human rhino- and enteroviruses in children with 
respiratory symptoms in Luanda, Angola. Accepted for publication in Paediatrics and international child 
Health; with kind permission from maney Publishing (www.maneypublishing.com/index.php/journals/pch). 
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8.2 Chronic suppurative otitis media – clinical and microbiological 
variables [ii]
Background characteristics, medical history, and clinical findings were compared 
between 23 children with and 23 controls without CSOM (Table 7). CSOM was 
bilateral in 10 of the 23 (43%) cases, and its duration ranged from 2 months to 7 
years (median 12 months). Six (26%) CSOM children suffered from both HIV and 
tuberculosis. None of the 23 children with CSOM exhibited intra- or extracranial 
complications.
The bacterial aetiology of CSOM appeared monomicrobial in all 18 bacterial-
positive cases and comprised Proteus (8, 44%), Pseudomonas (4, 22%), Shigella 
(1, 6%), and Haemophilus (1, 6%) species. Four (22%) smears remained culture 
negative. Among these bacteria, antibiotic resistance was common against amo-
xicillin (64%), amoxicillin-clavulanic acid (60%), and trimethoprim-sulpha (71%), 
but no resistance occurred against ciprofloxacin or third-generation cephalosporins.
Among the CSOM children, slight-to-severe hearing loss (PTA or BAEP 28 to 
80 dB HL) occurred in 52% (17/33) of the discharging ears, and slight hearing loss 
(PTA 28 to 31 dB HL) occurred in 23% (3/13) of the non-discharging ears, of which 2 
had dry TM perforations and one a retracted TM. Bilateral hearing loss was present 
in 30% (7/23) of the CSOM children, and 6 children exhibited a PTA threshold > 
30 dB HL in the better ear.  Only one 8-year-old child had had attention paid pre-
viously to his hearing loss. None of the control children had bilateral hearing loss. 
8.3 sickle-cell disease-associated otorhinolaryngological  
pathology [iii]
This study comprised 61 children with and 61 controls without SCD. Both groups 
included 36 (59%) boys, and the median ages of the children were 4.9 years (range 
0.7-15.7) in the SCD and 4.8 (range 0.8-13.7) in the control group. Among the SCD 
children, 41 (67%) took regular medication (mainly folic acid, paracetamol, and 
ibuprofen), and 12 (19%) had received blood transfusions. For no SCD children 
were penicillin prophylaxis and pneumococcal vaccines available. 
Table 8 shows that no significant differences occurred among the SCD vs. control 
children in ORL findings, including middle-ear and TM pathology. 
In pure-tone audiometry screening, failure to hear a 25 dB HL stimulus at one 
or more frequencies was the case for 15 (60%) SCD- and 14 (50%; p=0.465) control 
children. Bilateral hearing loss occurred in 9 (36%) SCD and 3 (11%; p=0.047) cont-
rol children (Figure 8). These hearing losses were of slight degree (30-40 dB HL), 
except for solitary losses of moderate degree in two SCD and two control children. 
None appeared to need a hearing aid. In SCD vs. control children, neither the ave-
rage hearing thresholds nor the failure rates differed significantly at any frequency.
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table 7. selected background features and clinical findings of children with (n=23) and without (n=23) 
chronic suppurative otitis media (csom) in Luanda, Angola. comparisons by Pearson’s chi-square and 
Fisher’s exact tests. Adapted from: taipale A, Pelkonen t, taipale m, Bernardino L, Peltola H, Pitkäranta 
A. chronic suppurative otitis media in children of Luanda, Angola. 2011; 100: 84-88. © 2011 the Authors / 
Acta Paediatrica © 2011 Foundation Acta Paediatrica. 
csom children  
n (%)
controls         
n (%)
     p value
Background features
 Female 11 (48) 11 (48)
 median age (years);
  range
4.3;                       
1.1–11.5
4.5;                  
0.8–12.5
 number of children in the household; 
  range 
2;                            
1–7
3;                      
1–7
0.583
 running water at home 8 (35) 6 (26) 0.749
 electricitya at home 16 (70) 16 (70) >0.999
 Attendance at national vaccination 
  program
20 (87) 17 (74) 0.265
 median duration of breastfeeding, 
  months (range)
18 (1-24) 18 (3-37) 0.114
 earlier episodes of otorrhoea 23 (100) 3 (14) < 0.001
 ear pain, earlier or currently 23 (100) 0 < 0.001
Clinical findings
 Acute pulmonary infection 9 (39) 1 (4) 0.010
 cervical lymphadenopathy > 1cm 15 (65) 5 (22) 0.007
 tuberculosis 8/22 (36) 0 0.002
 HiV positivity 14/22 (64) 0 < 0.001
 malnutrition 8 (35) 2 (9) 0.071
a during several hours 1-2 times daily through public electric transmission
0
2
4
6
8
10
12
14
0
5
10
15
20
25
30
0.125 kHz 0.25 kHz 0.5 kHz 1 kHz 2 kHz 4 kHz 6 kHz 8 kHz
N
um
ber of children
D
ec
ib
el
s
SCD (failures)
Control (failures)
SCD (mean threshold)
Control (mean threshold)
Figure 8. mean hearing thresholds in decibels (lines; left vertical axis), and the numbers of children failing 
to hear a 25 dB stimulus with their better ears (columns; right vertical axis), among 25 children with sickle-
cell disease (scd) and 28 controls in Luanda, Angola. Adapted from: taipale A, Pelkonen t, Bernardino L, 
Peltola H, Pitkäranta A. Hearing loss in Angolan children with sickle-cell disease. Pediatrics international 
2012; 54: 854-857. © the Authors. Pediatrics international © Japan Pediatric society.
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table 8. otorhinolaryngological profiles in 61 children with sickle-cell disease (scd), their 61 controls, and 
78 children with human immunodeficiency virus (HiV) and their 78 controls in Luanda, Angola (compared 
by Pearson’s chi-square and Fisher’s exact tests).  
scd HiV
Patients     
n (%)
controls    
n (%) p value
Patients     
n (%)
controls     
n (%) p value
History
 otalgia 25 (41) 31 (51) 0.276 44 (56) 27 (35) 0.006
 otorrhea 
  episodes 6 (10) 11 (18) 0.191 34 (44) 17 (22) 0.004
 Hearing 
  complaints 5 (8) 9 (15) 0.395 6 (8) 9 (12) 0.415
 speech delay 1 (2) 2 (3) >0.999 2 (3) 1 (1) >0.999
Current findings
 respiratory 
  infection 29 (48) 22 (36) 0.286 55 (71) 25 (32) <0.001
 dermal lesionsa 3 (5) 3 (5) >0.999 25 (32) 4 (5) <0.001
 oral 
  candidiasis 1 (2) 3 (5) 0.619 9 (12) 5 (6) 0.402
 dental caries 26 (43) 23 (38) 0.580 44 (56) 25 (32) <0.001
 tonsillar 
  hypertrophyb 10 (16) 6 (10) 0.334 1 (1) 6 (8) 0.063
 salivary gland 
  hypertrophy 2 (3) 0 0.496 2 (3) 0 0.497
 cervical lymph 
  nodesc 11 (18) 4 (6) 0.096 35 (45) 8 (10) <0.001
 Acute otitis 
  media 2 (3) 4 (6) 0.680 8 (10) 9 (12) >0.999
 chronic 
  suppurative 
  otitis media
0 2 (3) 0.496 21 (27)d 3 (4) <0.001
 middle-ear 
  effusion 1 (2) 1 (2) >0.999 0 0 >0.999
 dry tympanic 
  membrane 
  perforation
1 (2) 53 (48) >0.999 7 (9) 1 (1) 0.063
 cerumen 
  impaction 27 (44) 30 (49) 0.586 26 (33) 34 (44) 0.249
a maculopapular eczema, folliculitis, molluscum contagiosum 
b At least 50% of the space between pillars 
c At least 1 cm 
d eight (38%) cases bilateral
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Of the 15 SCD children (6 to 16 years old) who exhibited uni- or bilateral hea-
ring loss, 2 children (3 ears) had cerumen impaction; of the rest, none manifested 
AOM, MEE, or TM perforations. Two children had previously noticed their own 
hearing loss.
8.4 human immunodeficiency virus-associated otorhinolaryn-
gological pathology [iV]
This study compared ORL status in 78 HIV-positive children and 78 controls. The 
median age in the HIV vs. control group was 4.3 years (range 0.8-14.8) vs. 4.1 years 
(range 0.8-13.7), and both groups included 36 (46%) boys. Of the HIV-positive 
children, 41 (53%) showed clinical signs of advanced or severe disease according 
to WHO criteria; 36 (46%) received antiretroviral treatment, 61 (78%) antibiotics 
(mainly sulfa-methoxazole), and 5 (6%) anti-tuberculosis treatment. Concurrent or 
previous diagnosis of tuberculosis occurred in 22/77 (29%) HIV-positive children 
vs. 2/77 (3%; p<0.001) controls, current diagnosis of pneumonia in 17 (22%) HIV-
positive vs. 2 (3%; p<0.001) controls, and current hepatomegaly in 8 (10%) HIV-
positive vs. zero controls (p=0.007).
Major differences emerged in the ORL findings among the HIV-positive vs. 
control children, as described in Table 8. None of the clinical variables inside the 
HIV group were associated with these children’s antiretroviral treatment status. 
Hearing screening by BAEP was performed in all study children, and 29 HIV-
positive and 31 control children also underwent audiometry. No data on hearing 
could be obtained in 2 young control children (3 ears), in whom BAEP screening 
failed, and pure-tone audiometry was nonfeasible. After combining the results from 
these two screening methods, 20 (26%) HIV-positive and 12 (15%) control children 
exhibited slight-to-profound hearing loss. Bilateral hearing loss was present in 10 
(13%) HIV-positive children vs. one (1%; p=0.009) control child. In the HIV-posi-
tive children, otoscopy of the 30 hearing-impaired ears revealed CSOM (12; 40%), 
cerumen impaction (7; 23%), dry TM perforation (5; 17%), intact, mobile TM (4; 
13%), and retracted TM (2; 7%). Hearing defects among the HIV-negative children 
(13 ears) related to cerumen (5; 38%), to unknown factors (5; 38%), to AOM (2; 
15%), and to CSOM (1; 8%).   
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9. discussion
9.1 the role of picornaviruses in tropical respiratory infections
In the present study, screening picornaviruses in children with respiratory symptoms 
from various outpatient clinics, the incidence of respiratory symptoms increased 
in the cool season. Picornaviruses occurred at young ages, a median 3 years, with 
symptoms of fever, rhinorrhea, and cough. The frequencies of these symptoms, as 
well as otitis media (discussed later in detail) and pneumonia, showed no alteration 
related to the children’s picornavirus positivity or underlying chronic conditions. 
Furthermore, neither HIV infection, SCD, nor malnutrition associated with picor-
navirus positivity.     
In this sample, proportions of children with HIV infection and SCD were highly 
overrepresented in relation to those of the general population. This is largely due to 
the high contribution of these chronic illnesses to health care: In the mid-2000’s, 
systematic HIV testing of patients in the Paediatric Hospital of Luanda revealed 
roughly one-fifth to be HIV positive.216 Notably, the present study’s SCD and HIV 
children exhibited no higher frequencies of acute respiratory symptoms than in 
control children.
Here, prevalence rates for HRV and HEV positivity were consistent with tho-
se in other recent studies conducted among outpatients in subtropical or tropical 
countries.48,49,51,217,218 Strictly speaking, the present study could verify no causality 
between viral shedding and clinical infection, as that would have demanded serial 
NPS sampling, and obtaining and processing multiple samples from the same in-
dividuals would have posed excessive economic and logistical challenges regarding 
the study context.
Our findings suggest that HRV transmission may increase in the tropics at dec-
reasing temperatures: HRV caused nearly half of all RTI cases in the coolest month 
of July. However, the limited study period (April to July), as well as the relatively 
small sample size, restricts further speculation on picornavirus seasonality. None 
of the larger-scale studies from tropical regions reported a clear seasonality for 
picornaviruses: association with weather parameters went either undetectable48,49 
or unanalyzed.217 A cohort study from tropical Brazil perceived a peak in HRV in-
cidence during the local autumn, however.50
Knowledge of the aetiology and epidemiology of RTIs is recognized to be of ma-
jor importance in developing countries where these diseases carry high morbidity 
and mortality.219 Until recently, HRV has been considered a rather harmless virus 
responsible mainly for mild RTI symptoms, and it has gained little attention in 
research in developing countries. Because up-to-date evidence links HRV not only 
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to lower RTIs,21,22,33,48,53,220-222 but also to invasive pneumococcal diseases,223,224 and 
even to meningitis,39 research on picornavirus infections in developing countries 
becomes more relevant. In addition, the underlying nutritional or immune defi-
ciencies and their impact on the clinical picture and outcomes of common cold 
deserve more attention. 
Because the multiplicity of HRV and HEV types hampers effective vaccine deve-
lopment, restricting the transmission of these viruses remains the major preventive 
measure.219 Further research is therefore needed on the epidemiological and clinical 
aspects of HRV and HEV infections in developing countries.         
9.2 middle-ear pathology
9.2.1 Otitis mEdiA As A COmpliCAtiOn OF rEspirAtOry inFECtiOn
AOM occurred in one-quarter of the children with picornavirus infections. More than 
half of all AOM children who underwent NPS sampling actually yielded picornavi-
rus, but this association lacked statistical significance. Should any real association 
between AOM and picornaviruses among all RTI-causative agents have existed, 
demonstrating it would probably have demanded a considerably larger sample 
size, because of the high overall frequency of AOM during viral RTIs. As such a 
high proportion of children with RTI will develop AOM anyway, picornaviruses 
may not, from an epidemiological point of view, outweigh other aetiopathological 
viral agents of AOM in their middle-ear invasiveness but simply by their higher 
frequency.  Actually, the proportions of AOM and picornaviral RTI that we obtained 
agree with findings from temperate climates, where picornavirus RTIs lead to AOM 
in approximately one out of three cases,18 and were present in up to half the AOM 
children.41,42,57,58
 This study suggests a marked involvement of picornaviruses in the AOM comp-
lication of tropical common colds. The extent of this involvement remains a subject 
for further research in the quest for more accurate characterization of AOM –   the 
major pathway to CSOM in areas of a high burden of chronic otitis media.   
9.2.2 ChrOniC suppurAtiVE Otitis mEdiA
We evaluated CSOM in children with otorrhoea of up to 7 years’ duration. Studies 
from developing countries verify that children may suffer from extremely longstan-
ding otorrhoea, because treatment is delayed or lacking.70,81,111,112,225 The median age 
of our CSOM children was 4 years. Several earlier studies corroborate the young age 
of CSOM patients.65,73,112,115,116,225 As for ours, more than 40% had bilateral disease, 
similar to common findings in childhood CSOM in developing countries.70,73,80,82,112,225 
All of these features  long duration, early onset, and a tendency toward bilaterality 
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– underline the importance of prompt treatment of CSOM during the child’s critical 
age of linguistic and cognitive development.
The present study excluded children whose otorrhoea had persisted for less than 
2 months. Worldwide, the definition of CSOM is not uniform, and durations of at 
least 2 weeks to 3 months have been suggested as defining middle-ear discharge as 
being chronic. In the Paediatric Hospital of Luanda, the vast majority of children 
with otorrhea had at least several months’ history of the disease, and thus the data 
obtained by applying the cut-off limit of 2 months represented the actual patient 
material well.
Our most frequent bacterial causative agents were Proteus and Pseudomo-
nas species. This is indeed typical of developing countries,65,66,69-71,73,112 except that 
Staphylococcus aureus was absent from our patients. However, our sample size 
was limited, and therefore coincidence most probably explains this non-emergence 
of Staphylococci. Additionally, pus sampling from the ear canal, instead of as an 
aspirate directly from the middle ear, may have led to a higher risk of contaminati-
on. On the other hand, one study from India detected no difference between these 
two sampling methods, and so our results may be considered rather reliable.226
 The high frequency of opportunistic Gram-negative rods reflects the poor ge-
neral state of health and the prolonged disease process in our CSOM children and 
thus points to their condition’s severity.
Mycobacterium diagnostics, had it been performed, would have provided valu-
able additional information because pulmonary tuberculosis occurred in more than 
one-third of our CSOM children. Considering this high tuberculosis prevalence, 
as well as the severity of hearing loss in some patients, some of our children may 
actually have suffered from aural tuberculosis. In general, tuberculous otorrhea is 
regarded as a rare disease offering diagnostic challenges.227,228 In future, a study 
on mycobacterial CSOM among HIV-positive children in resource-poor settings 
would be of value. 
No intra- or extracranial complications of CSOM were encountered. This was 
rather expected, as the CSOM children were outpatients visiting the clinic for other 
reasons. However, because complications of CSOM continue to cause morbidity 
and mortality in children of sub-Saharan Africa, the subject requires research in 
the settings where such cases more likely will emerge, i.e. in ORL clinics or during 
acute health care. For the same reason – CSOM-induced adverse outcomes – general 
research on childhood CSOM in developing countries needs to continue. 
9.2.3 middlE-EAr pAthOlOGy in siCklE-CEll disEAsE
Regarding the impact of SCD on childhood middle-ear infections in Luanda, un-
expectedly, SCD children only occasionally exhibited middle-ear pathology, des-
pite their lack of penicillin prophylaxis and pneumococcal vaccines. Few reports 
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concerning otitis media in SCD children exist: 3 hearing-screening studies (2 from 
the USA, one from Nigeria), reported MEE in up to 27.5%.139,142,159 Of these, one US 
study perceived an increased prevalence of middle-ear pathology in SCD vs. control 
children,142 while in Nigeria the rates appeared equal.139 In addition, a retrospective 
survey from the USA detected fewer tympanostomy-tube insertions in SCD children 
than in a historical SCD-free cohort.229 Recurrent, persistent, and complicated epi-
sodes of otitis media are, however, characteristic of children without haemoglobi-
nopathies but with antibody deficiencies.165,230,231 SCD children with their weakened 
splenic function might therefore be expected to show a tendency towards acute and 
chronic otitis and its severe suppurative complications, but actual evidence on the 
subject remains small and controversial. 
Possible explanations for the absence of middle-ear pathology among our SCD 
children include a better clinical balance in this group, when compared to the worse-
off majority not followed up at the SCD clinic; survival of children with a milder 
form of SCD (the most severe cases leading to early mortality); and, finally, mere 
coincidence. Concerning this study, we must also emphasize the possibility of mis-
sing small amounts of MEE in young children with suboptimal otoscopic views due 
to impacted cerumen in the ear canal. Future studies should include a larger and 
wider sample of SCD children and controls, as well as follow-up.
Some studies suggest only a low proportion of Streptococcus pneumoniae in bac-
teraemia of SCD children in malaria-endemic regions; this has raised the question 
whether malaria-induced splenomegaly could partially preserve splenic function in 
these children.232,233 Malaria may thus be one of the environmental factors modifying 
the course of SCD. A follow-up study is required to verify the impact of SCD on the 
incidence and course of childhood otitis media in low-resource, malaria-endemic 
regions where both SCD and otitis-related deaths occur. 
9.2.4 thE burdEn OF Otitis mEdiA in humAn immunOdEFiCiEnCy Virus–
pOsitiVE ChildrEn
In all HIV-positive children of the present study, CSOM was present in more than 
one-quarter and dry perforations in one-tenth. Our small and hospital-based samp-
les may have been biased, and our CSOM group probably exaggerates the true 
contribution of HIV in CSOM epidemiology. However, several studies confirm the 
high burden of chronic otitis in HIV-positive children,201-204 and reports also confirm 
the occurrence of systemic complications of otitis media among them.187,201
 No previous reports were available of incidence rates or wider statistics concer-
ning the role of HIV in otitis media and its complications in developing countries. 
In Brazilian HIV-positive children, management of HIV alleviated the burden of 
their otitis media.207 The impact of the HIV epidemic on the course and consequen-
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ces of CSOM is probably considerable in regions of high HIV prevalence, and thus 
deserves future research.
9.3 Otorhinolaryngological profiles in different patient groups
Of every ten of our children without clinical suspicion of HIV, seven exhibited ORL 
pathology, making ORL pathology apparently highly frequent. The most typical ORL 
symptoms and diseases were respiratory infections, lymph-node enlargement, ear 
pain, acute or chronic otitis media, and oral thrush. In children of developed count-
ries, RTIs234 and AOM235 are also usual. However, chronic otitis and oral candidiasis 
are ORL presentations typical of children who experience poor living conditions 
and nutrition and hygiene deficiencies. 
 In our children, cerumen impaction was frequent. The children or their care-
givers were only rarely familiar with the meaning or normal function of ear wax. 
Indeed, cerumen impaction is common in children of resource-poor countries and 
may even lead to clinically significant hearing loss.236-239 In children with already 
compromised hearing due to other causes, even slight additional cerumen-induced 
hearing loss may significantly worsen hearing ability. In general, not many studies 
concern the adverse effect of excessive cerumen on hearing. Among some adults in 
the UK, one-third benefited from removal of impacted cerumen, and even though 
the procedure improved hearing levels by an average of only 5 dB HL, some indi-
viduals’ hearing levels improved by up to 36 dB HL.240
  In populations with high prevalences of TM perforations, limited knowledge 
of anatomy of the ear, and poor availability of clean water or cerumenolytic agents, 
removal of cerumen should occur in health care centres with trained personnel, 
manual removal without irrigation probably being the most feasible method.     
In this study, of every ten HIV-positive children, no less than nine exhibited 
ORL pathology. This is consistent with reports that also uniformly suggest sub-
stantial ORL involvement in paediatric HIV infection.184-186,188 Compared to our 
controls, the present study’s HIV-positive children presented a higher number of 
pathologic findings with a more severe clinical picture. They had marked cervical 
lymphadenopathy and rampant caries more frequently, but so did some control 
children, as well. In the head and neck, bilateral CSOM and widespread eczema 
appeared particularly strong indicators of HIV positivity. Compared to earlier re-
ports, we detected HIV-associated oral candidiasis somewhat less and parotid en-
largement much less frequently.184-186,188 On the whole, our findings suggest that, 
as part of their medical follow-up, HIV-positive children should routinely undergo 
an ORL examination.
In contrast to the HIV patients, the present study was unable to demonstrate 
any significant elevations in the frequencies of ORL findings in the SCD children. 
No other comparative studies on the subject have emerged. The present study’s SCD 
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children also exhibited none of the reported ORL complications of SCD, such as 
deep infections, osteomyelitis, or marked tonsillar hypertrophy.166,170 This suggests 
that such findings are fairly unusual even in developing countries. However, because 
ORL complications of SCD do exist in case reports, defining their occurrence would 
be interesting in resource-poor settings where the majority of the patients live.
9.4 hearing loss
9.4.1 hEArinG lOss duE tO ChrOniC suppurAtiVE Otitis mEdiA
The present study detected at least slight hearing loss in half the CSOM ears and 
bilateral hearing loss in nearly one-third of CSOM children. Only one of these cases 
had been noticed by the family. These characteristics are consistent with findings 
in developing countries that of every 10 CSOM children,  hearing loss occurs in 5 
to 9.79-82,114-116  Data also show that both otorrhoea and hearing loss in children in 
resource-poor settings remain widely neglected.73,112,241 Unfortunately, the onset of 
CSOM during infancy may pose a higher risk for hearing loss.116 Chronic otitis media 
occurring at school age may cause hearing loss sufficiently severe to endanger scho-
lastic performance.82,117,239 Therefore, in resource-poor communities, more precise 
recognition of a child’s ear discharge as a warning sign is warranted in order to 
fully utilize existing resources for prevention of and rehabilitation of hearing loss. 
Information should be targeted to communal workers serving children and fa-
milies at clinics and schools, as well as to primary health care professionals. As 
CSOM children typically suffer from slight-to-moderate hearing loss, they would, 
even without access to hearing aids, be substantially supported by simple rehabili-
tative measures such as having seats in the front of the classroom, being addressed 
in a loud and clear voice, and making lip-reading more possible – instead of their 
being erroneously regarded as lazy or unintelligent.  
9.4.2 hEArinG lOss in siCklE-CEll disEAsE
In audiometric evaluation of our SCD children, screening failures occurred in three-
fifths of them and bilateral hearing loss in more than one-third. However, only 
bilateral hearing loss was significantly associated with SCD. The absence of evidence 
of middle-ear pathology suggests that the hearing impairment may have originated 
mainly from the inner ear. Of the 15 hearing-impaired SCD children, however, in 
2 (3 ears), cerumen impaction prevented reliable otoscopic and tympanometric 
evaluation and may have been the actual reason for compromised hearing. Only 
2 hearing-loss cases had previously been detectable. None presented with a PTA 
threshold >30 dB HL in the better ear, the current WHO standard for considering 
a hearing aid.4 The unexpectedly high hearing-loss rate among the present study’s 
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control children may have been coincidental, or a result of higher participation of 
families of children with ear- or hearing problems.  
We detected a relatively high rate of hearing loss compared to that for previo-
us researchers, particularly if losses attributable to middle-ear pathology in the 
earlier data are excluded. Notably, half the hearing-impaired children were only 
5 to 8 years of age, younger than in most studies, which predominantly examin-
ed older children.139,142-145 We thus highlight the risk for hearing loss in SCD that 
occurs even as early as at ages 5 to 6. In contrast to some reports,142,145 we found 
no severe impairment, which suggests that severe hearing loss occurs in children 
only rarely. However, even slight or fluctuating hearing loss may adversely affect 
a child’s speech development.242
 With improved management, more SCD children will survive in sub-Saharan 
Africa beyond early childhood.119 In these survivors, screening for hearing problems 
should be implemented in their routine care even at preschool age.  
9.4.3 hEArinG prOblEms in humAn immunOdEFiCiEnCy Virus-pOsitiVE 
ChildrEn
Among the HIV-positive children, some degree of hearing loss occurred in one-
quarter, and half of those suffered bilateral loss. More than half the hearing loss 
occurred in ears with TM perforations, the majority of which were actively di-
scharging. This is consistent with data in other studies from developing countries, 
showing hearing loss in 23 to 39%.191-194 These studies also frequently detected 
middle-ear pathology behind the impairment. In resource-rich settings, the pro-
portion of otitis media in HIV-associated hearing loss may be lower, but risk for 
hearing loss remains elevated.243
The present study confirms and underlines the importance of recognizing hea-
ring loss and treating otitis media promptly in HIV-positive children in developing 
countries, as well as the importance of screening their hearing on a regular basis.
9.5 practical and ethical viewpoints
Our study was conducted in a paediatric hospital in tropical Angola, where few 
data exist on childhood ORL problems. The study children were simply recruited 
among the hospital’s outpatients, which provides both strengths and limitations 
for the study. Obviously, the samples were highly biased compared to the general 
population: In addition to chronic underlying diseases, higher socioeconomic classes 
may have been overrepresented among the hospital’s outpatient population, as even 
public transportation to the hospital may have been too expensive for the poorest 
families. Moreover, factors such as higher education, positive family history, or 
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suspicion of existing ORL problems may have furthered the guardian’s decision to 
participate in the study. However, in developing countries, children ask for medical 
care due to ORL problems only rarely. These problems are and should therefore 
be screened for and detected during visits for other reasons; this underlines the 
clinical relevance of the present findings. 
In resource-poor Angola, basic ORL services, even ones such as otoscopic exa-
mination, are available only rarely. Soundproof facilities for hearing screening and 
ear-suction devices for cleansing the ear canal were nonexistent, and electricity was 
undependable. These circumstances contribute to this study’s limitations: pure-tone 
thresholds obtained, especially in the lowest frequencies, may be somewhat higher 
than in reality, and in some cases (especially in young children) not all cerumen 
could be removed from the ear canal. BAEP screening proved challenging due to 
excessive sweating when the air-conditioner was broken or lacked electricity. Such 
circumstances represent, however, the usual settings in health care and research 
practiced in resource-poor countries. 
Pure-tone thresholds were measured without masking the contralateral ear. Due 
to transaural bone conductibility, this may have resulted in erroneously low pure-
tone thresholds in the worse-hearing ears in children whose pure-tone thresholds 
differed by more than 50 dB HL. In addition, as no bone-conduction thresholds 
were measured, a distinction between conductive and sensorineural hearing loss 
was impossible. Furthermore, because in cochlear hearing loss the correlation bet-
ween hearing thresholds obtained by click-evoked BAEP vs. pure-tone audiometry is 
strong only at 2 to 4 kHz and remains weaker at lower frequencies,244 the ability of 
our BAEP measurements to detect such hearing loss cases was probably suboptimal. 
To be ethical, research in a resource-poor environment should have a clear pur-
pose,245,246 which, in the present study, was to collect epidemiological and clinical 
data on childhood ORL diseases affecting millions of children worldwide. In addi-
tion, making medically purposeful research ethically sustainable requires ethical 
evaluation by local professionals, as well as consent from the study attendants. The 
present study underwent ethical consideration in the Paediatric Hospital of Luan-
da.245,246 Because of limited literacy among Angolans, however, study information 
and consent toparticipate was handled orally. The majority of the guardians were 
familiar with neither the usual childhood ORL diseases nor the concept of medical 
research. 
According to Ruth Macklin, these examples represent a true dilemma for re-
search among resource-poor communities: should ethical guidelines arise from 
pragmatism or idealism; how can one create guidelines that are, as Macklin noted, 
“usefully prescriptive without being hopelessly aspirational”? In a culture which 
knows no basic concepts of medicine or medical research, how to adapt research 
procedures, such as obtaining informed consent, to the environment in such a way 
that the consent obtained becomes genuine? Macklin states that research concer-
ning a major health issue in the target population can be ethically justified, if no 
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possibility exists for conducting it in another population with more potential for 
understanding its content.247 In the team of our present study, the local professionals 
plus one member with long-term local experience lowered these cultural barriers.
In addition to the wider advantages for future patients, short-term research 
may locally provide for the participants “ancillary care” not directly related to the 
study protocol.245,246 Here, ancillary care (e.g. medical prescriptions) was provided 
when needed, but did not serve as a “decoy” in recruitment, although sometimes 
families with known ear complaints appeared more willing to participate in hope 
of free treatment. Leaving such families virtually without access to any treatment 
would have been the most unethical option. Unfortunately, in the absence of any 
local ORL service network, no follow-up for these children was available. 
In Luanda, resources for rehabilitation of the hearing impaired are poor. Some 
study participants could be advised to contact a local school for the hearing im-
paired, but hearing-aid rehabilitation was unavailable. However, in resource-poor 
communities, even recognizing the hearing impairment would help the child’s family 
and teachers to support the child in daily communication.236
ORL diseases and hearing loss in children of developing countries are largely 
neglected areas in medical research, with more data required. Worldwide, 90% of 
the need for hearing aids exists in developing countries, where only less than one 
in 40 will receive the required services.4
   In resource-poor countries, vast, unselective screening programs requiring 
expensive equipment and training of personnel may be unfeasible in the absence 
of any functioning referral and rehabilitation system. However, not to screen at 
all would inevitably lead to permanent disability for hundreds of thousands of 
hearing-handicapped children.248 More regional data on childhood hearing loss is 
therefore essential for targeted screening.7,14,249 Questionnaires are one tool proposed 
for identifying children in need of hearing screening. The present findings suggest 
that, should such questionnaires be applied, they should include the child’s HIV 
and possibly also SCD status. Additional simple methods for hearing assessment 
in primary health care, such as whispering tests,17,250 also need research and vali-
dation in developing countries. 
The child’s optimal cognitive and social development relies on adequate hearing, 
and underprivileged communities need the full potential of their children, the buil-
ders of the future. The lifetime cost of childhood hearing loss has been estimated 
to exceed that of the cases with later onset.7 In resource-poor settings, therefore, 
prevention and rehabilitation of hearing loss generally deserve higher priority, and 
the highest priority for these services should belong to children. 
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10.  summary and conclusions
A massive shortage of ORL services, education, and research exists in developing 
countries where the resource-poor environment poses risk factors for chronic and 
recurrent ORL diseases. The burden of ORL diseases remains therefore high in these 
areas among children. In sub-Saharan Africa, one ORL expert may serve millions 
of people, and awareness of ORL diseases in primary care remains limited. Hearing 
loss and its impact on society are under-recognized, and only one in 40 in need 
of hearing rehabilitation receives the needed device. In the children of Africa, the 
HIV epidemic and high prevalence of sickle-cell disease and tuberculosis further 
affect the pathology and conditions related to the ORL area. 
The present study was conducted in the Paediatric Hospital of Luanda, Ango-
la, to collect data on ORL pathology and hearing in children of various outpatient 
clinics, and particularly to define the occurrence of HRV and HEV during the cool 
season, the clinical and microbiological characteristics of childhood CSOM, and 
the HIV- and SCD-associated ORL findings and hearing loss. Background features 
and medical history came from the children’s guardians, and the children under-
went general physical and ORL examination, plus hearing screening by BAEP and 
pure-tone audiometry. 
Picornaviruses were evident in more than one-third of common-cold patients. 
Common-cold symptoms, as well as the proportion of rhinovirus as the causative 
agent, increased as the temperature fell. The virus-positive children were signi-
ficantly younger than the virus-negative, and AOM complicated the picornaviral 
RTIs in about one-quarter. In resource-poor living conditions, chronic ear discharge 
typically harbored gram-negative rods, and in the setting of outpatient clinics, the 
vast majority of the patients suffered from HIV or tuberculosis; approximately one-
third had slight-to-severe bilateral hearing loss. SCD children also presented with 
an ascending risk for hearing loss, mainly in the low and middle frequencies; these 
losses appeared slight, and the children exhibited no signs of the alleged susceptibi-
lity to otitis media. Abnormal ORL findings such as cervical lymphadenopathy, RTI, 
and otitis media were common in all children, but the children with HIV infection 
appeared to be major carriers of the burden of ORL diseases. Moreover, hearing 
loss was associated with HIV and mainly coincided with middle-ear pathology; the 
present study did not, however, rule out concomitant inner-ear pathology.       
Several conclusions can be drawn. This work suggests the marked involvement 
in sub-Saharan Africa of picornaviruses, particularly HRV, in AOM epidemiology. In 
order to prevent more severe forms and bacterial complications of viral RTIs, more 
complete understanding is needed for the epidemiology and clinical consequences 
of picornaviruses in tropical areas with low resources and high co-morbidity. 
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 Summary and conclusions
In developing countries, a child may grow up with chronic ear discharge and 
hearing loss without the guardians or even medical professionals recognizing the 
condition. Especially in areas of the HIV epidemic, the prevalence and epidemio-
logy of CSOM require updating. 
SCD may lead to hearing loss, and children aged 5 to 6 should already be un-
dergoing audiometric screening. However, the incidence and clinical picture of 
otitis media remains unclear among children with SCD in sub-Saharan Africa, and 
deserves a prospective follow-up study. 
Ear discharge, extensive rashes, and persistent cervical lymphadenopathy may be 
signs of underlying HIV infections, and follow-up of HIV-infected children should 
include thorough ORL status, hearing screening, and prompt treatment of middle-
ear infections. 
Focusing attention on children’s ears and hearing could substantially benefit 
many underprivileged communities. Both from the perspective of humanity and 
economy, these children are too valuable a resource to be wasted through preven-
table disability and suffering.
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aPPendix
Study forms translated from Portuguese originals.
HISTORY AND PHYSICAL EXAMINATION page 1
Study number____________
HOSPITAL PEDIÁTRICO DAVID BERNARDINO Gender Female
Date of admission:_______/________/__________ Male
Weight :________Kg                                        Upper middle arm circumference:___________ cm Height__________________cm
Head circumference:_________________cm Blood pressure_________/______mmHg, P__________
HISTORY YES NO Unknown
HOUSEHOLD SIZE __________persons, ______adults,______children
RUNNING WATER AT HOME___________________________________
ELECTRICITY AT HOME_____________________________________
BREASTFEEDING  Until___________________months
SOLID FOOD        Introduced at____________________months
ATTENDANCE AT VACCINATION PROGRAM_______________________
ANTES SAUDÁVEL__________________________________________
CHRONIC DISEASES_________________________________________
PREVIOUS DISEASES__________________________________________________________________________
MALARIA___________________________________________________
TYPHOID FEVER_____________________________________________
TUBERCULOSIS_____________________________________________
HIV / AIDS___________________________________________________
PREVIOUS ADMISSIONS______________________________________
MEDICATION; WHICH?________________________________________
ANTIBIOTIC;  WHICH?_________________________________________
QUININE BEFORE____________________________________________
SURGERY BEFORE__________________________________________
REASON FOR CONSULTATION__________________________________________________________________
EARACHE; Specify__________________________________
FEELS THAT HEARS WELL; Specify______________________________
HEARING PROBLEMS IN COMPARISON WITH OTHER CHILDREN 
HEARING DIFFICULTIES IN THE FAMILY_____________________________________
Specify______________________________________________________________________________________
PHYSICAL EXAMINATION YES NO Unknown
GOOD GENERAL CONDITION:_________________________________________
SIGNS OF MALNUTRITION:_____________________________________
slight mod. grave
FOCUS OF INFECTION Specify_____________________
HAEMOGLOBIN ___________________________g/dl
OTHER INFORMATION__________________________________________________________________________
Name:                                              Residence: 
 
Date of birth:                         Age:                   Telephone:  
72
page 2
OTORHINOLARYNGOLOGICAL STATUS YES NO Unknown
FACE NORMAL
Specify:  _____________________________________________________
AURICLES NORMAL 
Specify: ____________________________________________________
NOSE : Direct / Deviated ______________________________________________________________
NASAL SEPTUM: Direct / Deviated _______________________________________________________
RIGHT NOSTRIL: Rhinorrhea / Crust / Polyp / Normal _____________________________________________
LEFT NOSTRIL: Rhinorrhea / Crust / Polyp / Normal ______________________________________________
LIPS-GINGIVAS-PALATE NORMAL _____________________________________
Specify: cleft palate_____________________________________________________________________
DENTITION NORMAL____________________________________________________
TEETH: Healthy / Caries / Obturated / Missing__________________________________________________
ORAL MUCOSA NORMAL ________________________________________________________________
Specify:  Vesicles / Leukoplakia / Erythroplakia / Candidiasis_______________________________________
TONSILS NORMAL_________________________________________
Right tonsil: 0,  1,   2,   3,   4+ ___________________ Left tonsil: 0,  1,   2,   3,   4+  ______________________
UVULA NORMAL____________________________________________________
TONGUE: Normal / Big __________________________________________________________________
LINGUAL FRENULUM: Normal / Short _______________________________________________________
SPEECH NORMAL_________________________________________
Specify: Not comprehensible / Stuttering / Pronunciation difficulties _________________________________
VOICE: Clear / Hoarse ___________________________________________________________________
STRIDOR: Reason?________________________________________
EYE MOVEMENTS NORMAL__________________________________
Specify:  Right / Left / Strabismus / Nystagmus_________________________________________________
OTHER INFORMATION:____________________________________________________________________
DOCTOR'S SIGNATURE_________________________________________________________________
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page 3
OTORHINOLARYNGOLOGICAL STATUS YES NO UNKNOWN
PALPATION OF NECK NORMAL________________________________
Specify: Tumor / Cyst __________________________________________________________________
LYMPHADENOPATHY; Lymph nodes, size_______________________cm
FISTULES____________________________________________________________
Specify: Right / Left / Preauricular / Type I / Type II / Secretion
SALIVARY GLANDS NORMAL________________________________________
PAROTID Right: Left:
SUBMANDIBULAR Right: Left:
SUBLINGUAL Right: Left:
FACIAL NERVE NORMAL________________________________________________
FROWNING Dto: Esq:
CLOSING EYES Dto: Esq:
SMILING Dto: Esq:
WEBER_____________________________________________________________
RIGHT EAR LEFT EAR
RINNE
OTORRHEA 
OTOSCOPY: Auditory canal
OTOSCOPY: 
Tympanic membrane
Mobility of tympanic membrane
TYMPANOMETRY
HEARING TESTS
DATA 
NAME OF EXAMINATOR
BAEP COMPLETED
HEARING THRESHOLD, dB
OAE COMPLETED
OTHER INFORMATION_________________________________________________________
